Work

Medicare Spending on Drugs and Biologics Not Recommended for Coverage by International Health Technology Assessment Agencies

Year: 2019

Type: article

Source: Journal of General Internal Medicine

DOI: 10.1007/s11606-019-05149-6

Authors: Alexander C. Egilman, Joshua D. Wallach, Sanket S. Dhruva, Gregg S. Gonsalves, Joseph S. Ross

Institutions: Yale New Haven Hospital, Yale University, University of California, San Francisco, Yale New Haven Health System

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Veterans Affairs, Yale University, Laura and John Arnold Foundation, National Institutes of Health, National Center for Advancing Translational Sciences

Award: Yale Clinical and Translational Science Award

OpenAlex ID: W2956928845

FWCI: 0.935

Cites: 3

Cited by: 5

Related to: 10